Bsteh, G., Hegen, H., Riedl, K., Altmann, P., Auer, M., Berek, K., Di Pauli, F., Ehling, R., Kornek, B., Monschein, T., Rinner, W., Schmied, C., Wurth, S., Zebenholzer, K., Zinganell, A., Zrzavy, T., Zulehner, G., Deisenhammer, F., Rommer, P., Leutmezer, F., & Berger, T. (2021). quantifying the risk of disease reactivation after interferon and glatiramer acetate discontinuation in multiple sclerosis: The VIAADISC score. European journal of neurology, 28, 1609–1616. http://access.bl.uk/ark:/81055/vdc_100127476555.0x000013